English
Română
(
Romanian
)
Company
Presentation
Recognition and awards
CEO’s Message
Mission and values
Quality
Quality Policy
Certifications
Integrated Management System
Contract manufacturing
History
Investors
Information for shareholders
Events Calendar
Shareholder Structure
Stock Quotes
Dividends handout
Meeting with investors
Presentations
Events
Analist coverage
The General Meeting of Shareholders
Procedures of the General Meeting of Shareholders
Archive of The General Meeting of Shareholders
Management’s transactions
Affiliated persons’ transactions
Financial information
Financial reporting
Annual reports
News release and current reports
Contact for Investor Relations
Corporate Governance
Governance structure
Reference documents
Governance documents
Reports
Social responsability
National anti-corruption strategy
Whistleblowers in the Public Interest
Administrator selection procedure 2024
Development
Research
Regulatory Affairs
Biotechnologies
Centre for Drug Evaluation
Services
Studies
Clinical trials
Selecting volunteers
Products
Medicines for human use
Over the counter drugs
Nutriensa
Cosmetic products
Medicines with prescription
Medical devices
Active pharmaceutical ingredients
Veterinary products
VetAria+
Pharmacovigilance
Partners
Local Partners
Foreign partners
Nystatin
Finished products
Antibiotice in the world
Media
News
Media Relation Contact
Press Releases
Public Interest Announcements
Processing personal data
European Projects
Careers
Staff training
Summer School a+
Open Positions
Sport partnerships
Academic Partnerships
Involvement in training the health care professionals
Sustainability
ESG Reports
ESG Commitments
Environmental
Social
Governance
Responsible for future generations
“Science and Soul” Foundation
ESG Assessments and Ratings
Online orders
Contact
Company Info
How to contact us
Complains
Side effects from Saudi Arabia
Home
>
Investors
>
Corporate Governance
> Corporate Governance Regulation
Corporate Governance Regulation (…in working progress)
